Research Briefs: Abbott Peripheral Stent Data; Biotronik MRI Pacemaker Study
This article was originally published in The Gray Sheet
Executive Summary
Six-month data from the ESPRIT trial show that Abbott’s Esprit BVS, a peripheral stent based on the same technology as the Absorb BVS, reduces symptoms and keeps arteries open. Biotronik also announced that it has moved into the second phase of an MRI-compatibility trial of its Entovis pacemaker. More research news.
You may also be interested in...
Challenges For Bioresorbable Stents In Peripheral Arterial Disease
Are bioresorbable stents for peripheral arterial disease losing their luster, even before getting to the market? Expectations for drug-eluting balloons seem to be soaring at stent’s expense.
Challenges For Bioresorbable Stents In Peripheral Arterial Disease
Are bioresorbable stents for peripheral arterial disease losing their luster, even before getting to the market? Expectations for drug-eluting balloons seem to be soaring at stents’ expense.